Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 18/2023

Content (10 Articles)

Acknowledgement to Referees

  • Acknowledgement to Referees

Current and Emerging Treatment Options for Uterine Fibroids

  • Review Article

Mohamed Ali, Michał Ciebiera, Marta Wlodarczyk, Samar Alkhrait, Elise Maajid, Qiwei Yang, Shih-Min Hsia, Ayman Al-Hendy

HIV Pre-Exposure Prophylaxis: New and Upcoming Drugs to Address the HIV Epidemic

Christina G. Rivera, John D. Zeuli, Bradley L. Smith, Tanner M. Johnson, Ramona Bhatia, Ashley O. Otto, Zelalem Temesgen

Aetiology of Significant Liver Test Abnormalities in a Single-Centre Cohort of People with Cystic Fibrosis Exposed to Elexacaftor/Tezacaftor/Ivacaftor, Utilizing the Updated RUCAM

Daniel Tewkesbury, Andrew M. Jones, Rowland Bright-Thomas, Alyn Cratchley, Karen Piper Hanley, Judith Wyatt, Varinder Athwal, Peter J. Barry

Momelotinib: First Approval

Susan J. Keam

Iruplinalkib: First Approval

Susan J. Keam

Gepirone Extended-Release: First Approval

Susan J. Keam

Nedosiran: First Approval

  • Open Access
  • AdisInsight Report

Yahiya Y. Syed

Correction: Elacestrant: First Approval

Sheridan M. Hoy

Correction to: Motixafortide: First Approval

Sheridan M. Hoy

Nov 23
Issue: 17/2023
Jan 24
Issue: 1/2024

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images